Dextrose and Sodium Chloride (Dextrose monohydrate and sodium chloride) NDC 63323-870

Product information

Brand name (proprietary)

Dextrose and Sodium Chloride

Generic name (nonproprietary)

dextrose monohydrate and sodium chloride

Active ingredients

Dextrose monohydrate — 5 g/100mLSodium chloride — .9 g/100mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

Fresenius Kabi USA, LLCNDC labeler code 63323

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 211211

Marketing start

Oct 26, 2020

Listing expires

Dec 31, 2027

Other FDA classes

Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)

Identifiers

Product ID 63323-870_449bf5b8-ff7c-4d79-a1d2-03886440257dSPL ID 449bf5b8-ff7c-4d79-a1d2-03886440257dSPL set ID 68cc9c41-ed24-4f76-8efb-2936ae3ddd8dRxCUI 1795344, 1795346UNII LX22YL083G, 451W47IQ8X

Pharmacologic class

Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323087010 followed by a unit qualifier and the quantity Copy

Package 63323-0870-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

About NDC 63323-870

What is NDC 63323-870?

63323-870 is the product NDC for Dextrose and Sodium Chloride, Dextrose monohydrate 5 g/100mL; Sodium chloride .9 g/100mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Dextrose and Sodium Chloride (DEXTROSE MONOHYDRATE and SODIUM CHLORIDE).

What is the active ingredient?

Dextrose monohydrate, Sodium chloride.

Who is the labeler?

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextrose and Sodium Chloride?

21 other product NDCs are listed under this name. See all Dextrose and Sodium Chloride NDCs.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory. See Billing references above.

Related NDCs: other Dextrose and Sodium Chloride products

Other finished products listed under the same name: strengths, forms and labelers.

All 22 Dextrose and Sodium Chloride NDCs

Other NDCs under ANDA 211211

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.